Event

The complex microbiology of lower respiratory samples has thwarted attempts to develop broad molecular diagnostic panels in this area. BioFire has developed a test (currently IUO) which will identify 18 bacteria, 9 viruses, and 7 genetic markers of resistance in commonly collected lower respiratory specimens all in one hour. This symposium will feature Dr. Buchan and Dr. Stromich from the Medical College of Wisconsin, a clinical trial site for the BioFire Pneumonia Panel. Dr. Stormich will present patient cases from the clinical trial and discuss which patient populations will benefit most from the panel. Dr. Buchan will present an analysis exploring how frequently a pneumonia panel result can effectively tailor antimicrobial therapy.